A Study of Gantenerumab in Participants With Mild Alzheimer Disease

Clinical trial NCT02051608 · COMPLETED

Trial details

NCT number: NCT02051608
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2014-03-27
Primary completion: 2021-04-16
Enrollment: 389

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.